A detailed history of Aberdeen Wealth Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Aberdeen Wealth Management LLC holds 2,315 shares of MRNA stock, worth $273,910. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,315
Holding current value
$273,910
% of portfolio
0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $197,631 - $267,243
2,315 New
2,315 $246,000
Q2 2021

Jul 23, 2021

SELL
$129.91 - $234.98 $129,910 - $234,980
-1,000 Reduced 30.17%
2,315 $544,000
Q1 2021

May 13, 2021

BUY
$109.18 - $185.98 $19,106 - $32,546
175 Added 5.57%
3,315 $434,000
Q4 2020

Feb 10, 2021

BUY
$65.74 - $169.86 $15,383 - $39,747
234 Added 8.05%
3,140 $328,000
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $157,912 - $275,634
2,906 New
2,906 $206,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Aberdeen Wealth Management LLC Portfolio

Follow Aberdeen Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aberdeen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aberdeen Wealth Management LLC with notifications on news.